Health outcomes following COVID-19 infection and vaccination in hereditary hemorrhagic telangiectasia
Abstract Background There has been concern that individuals living with Hereditary Hemorrhagic Telangiectasia (HHT) could be at higher risk for poor outcomes if infected with SARS-CoV2, the virus that causes COVID-19 disease. As literature is lacking on outcomes on COVID-19 infection and vaccination...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2025-03-01
|
| Sarja: | Orphanet Journal of Rare Diseases |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s13023-025-03561-2 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|